Lacey S F, Weinhold K J, Chen C H, McDanal C, Oei C, Greenberg M L
Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
AIDS Res Hum Retroviruses. 1998 Apr 10;14(6):521-31. doi: 10.1089/aid.1998.14.521.
CD8+ T lymphocytes from HIV+ individuals can potently suppress HIV-1 replication in a noncytolytic manner. This suppression appears to be multifactorial and the molecules contributing have not been fully elucidated. As an approach to this question we used herpesvirus saimiri (HVS) to transform CD8+ T lymphocytes from an HIV+ asymptomatic donor to a continuously growing, activation-independent, IL-2-dependent phenotype. The transformed cell population, termed CD8(HVS), had an activated phenotype, contained HVS sequences, did not shed infectious HVS virus, and was polyclonal. The CD8(HVS) cells, despite the absence of detectable CTL activity, potently suppressed HIV-1 production by both autologous and heterologous CD4+ cells from infected donors. The CD8(HVS) cells in coculture also suppressed virus production from PBMCs acutely infected with syncytium-inducing (SI) strains or NSI primary isolates of HIV-1. The supernatants from the CD8(HVS) cells and their concentrates derived from these supernatants were suppressive to NSI primary isolates of HIV-1 but not to SI strains. Fractionation of these concentrates showed that the suppressive activity was associated with low molecular mass (6500- to 19,300-Da) protein species. Western blotting and ELISA indicated that the CC chemokines MIP-1alpha, MIP-1beta, and RANTES were present in these fractions. Antibody-blocking studies with antibodies to the CC chemokines indicated that a significant portion of the soluble HIV-suppressive activity was due to these molecules. However, these experiments also suggested the inhibitory activity of the CD8(HVS) cells in coculture is not due exclusively to the CC chemokines. The HVS-transformed cells provide a useful tool for the study of noncytolytic CD8+ T lymphocyte-mediated suppression of HIV-1.
来自HIV阳性个体的CD8 + T淋巴细胞能够以非细胞溶解方式有效抑制HIV-1复制。这种抑制作用似乎是多因素的,且起作用的分子尚未完全阐明。作为解决这个问题的一种方法,我们使用赛米利疱疹病毒(HVS)将一名HIV无症状供体的CD8 + T淋巴细胞转化为持续生长、不依赖激活、依赖白细胞介素-2的表型。转化后的细胞群体称为CD8(HVS),具有激活的表型,含有HVS序列,不释放有传染性的HVS病毒,并且是多克隆的。尽管没有可检测到的CTL活性,CD8(HVS)细胞仍能有效抑制来自受感染供体的自体和异源CD4 +细胞产生HIV-1。共培养中的CD8(HVS)细胞也抑制了被HIV-1的合胞体诱导(SI)株或NSI原代分离株急性感染的PBMC产生病毒。CD8(HVS)细胞的上清液及其从这些上清液中获得的浓缩物对HIV-1的NSI原代分离株具有抑制作用,但对SI株无抑制作用。对这些浓缩物进行分级分离表明,抑制活性与低分子量(6500至19,300道尔顿)的蛋白质种类有关。蛋白质免疫印迹法和酶联免疫吸附测定表明,CC趋化因子MIP-1α、MIP-1β和RANTES存在于这些级分中。用针对CC趋化因子的抗体进行的抗体阻断研究表明,可溶性HIV抑制活性的很大一部分归因于这些分子。然而,这些实验也表明共培养中CD8(HVS)细胞的抑制活性并非完全归因于CC趋化因子。HVS转化细胞为研究非细胞溶解的CD8 + T淋巴细胞介导的HIV-1抑制提供了一个有用的工具。